论文部分内容阅读
目的探讨米索前列醇治疗产妇产后出血的临床效果情况。方法 50例产后出血产妇,依据药物的不同分为米索前列醇组(30例)和对照组(20例)。对照组产妇给予缩宫素治疗,观察组产妇在对照组基础上给予米索前列醇治疗。观察两组产妇产后出血治疗有效率和不良反应发生率。结果米索前列醇组产妇产后出血治疗有效率为100.0%,高于对照组的80.0%,差异有统计学意义(P<0.05)。米索前列醇组产妇不良反应发生率为10.0%,低于对照组的35.0%,差异有统计学意义(P<0.05)。结论米索前列醇治疗产妇产后出血效果良好,不良反应发生率低,值得临床推广应用。
Objective To investigate the clinical effect of misoprostol in treating postpartum hemorrhage. Methods Fifty postpartum hemorrhagic pregnant women were divided into misoprostol group (n = 30) and control group (n = 20) according to the different drugs. The control group of women given oxytocin treatment, the observation group of women in the control group on the basis of misoprostol treatment. Observe the two groups of maternal postpartum hemorrhage treatment efficiency and adverse reaction rate. Results The effective rate of misoprostol treatment of postpartum hemorrhage was 100.0%, which was higher than that of the control group (80.0%), the difference was statistically significant (P <0.05). Misoprostol group maternal adverse reaction rate was 10.0%, lower than 35.0% in the control group, the difference was statistically significant (P <0.05). Conclusion Misoprostol treatment of postpartum hemorrhage with good results, the incidence of adverse reactions is low, worthy of clinical application.